Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1982-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.79.23.7518PMID 6296837PMCID PMC347371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Structural polypeptide VP1 in poliovirus type 1 induced by neutralizing antibodies].

  1982cited by this paper
• The adsorption and degradation of foot-and-mouth disease virus by isolated BHK-21 cell plasma membranes.

  1982cited by this paper
• Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

  1982cited by this paper
• A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.

  1981cited by this paper
• Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine.

  1981cited by this paper
• Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.

  1979cited by this paper
• Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages.

  1979cited by this paper
• Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents.

  1979cited by this paper
• Picornaviridae: second report.

  1978cited by this paper
• Structure of the Mengo virion. V. Distribution of the capsid polypeptides with respect to the surface of the virus particle.

  1977cited by this paper
• Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.

  1977cited by this paper
• Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity.

  1976cited by this paper
• Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.

  1975cited by this paper
• Antigenic Specificity of Poliovirus-Related Particles

  1971cited by this paper
• VP 4, the D-reactive part of poliovirus.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Composition of artificially produced and naturally occurring empty capsids of poliovirus type 1.

  1967cited by this paper
• Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope.

  1962cited by this paper
• The adsorption and early fate of purified poliovirus in HeLa cells.

  1961cited by this paper
• Studies on the complement-fixing antigens of poliomylitis. II. Preparation of type-specific anti-N and anti-H indicator sera.

  1960cited by this paper
• The D to C change in poliovirus particles.

  1959cited by this paper
• Immunochemical studies of poliovirus. III. Further studies on the immunologic and physical properties of poliovirus particles produced in tissue culture.

  1958cited by this paper
• Studies on the complement fixing antigens of poliomyelitis. I. Demonstration of type and group specific antigens in native and heated viral preparations.

  1958cited by this paper

• The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.

  2023cites this paper
• Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses

  2022cites this paper
• The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus

  2019cites this paper
• Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine

  2018cites this paper
• Defining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?

  2016cites this paper
• Broad spectrum assessment of the epitope fluctuation--Immunogenicity hypothesis.

  2015cites this paper
• Site-directed in vitro mutagenesis of Enterovirus EV71: implications for the development of an attenuated EV71 vaccine

  2013cites this paper
• Immunogenicity of enterovirus 70 capsid protein VP1 and its non-overlapping N- and C-terminal fragments.

  2005cites this paper
• Expression of enterovirus 70 capsid protein VP1 in Escherichia coli.

  2004cites this paper
• Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry.

  2004cites this paper
• Cholesterol Removal by Methyl-β-Cyclodextrin Inhibits Poliovirus Entry

  2004cites this paper
• Cholesterol Removal by Methyl- (cid:2) -Cyclodextrin Inhibits Poliovirus Entry

  2003cites this paper
• Parvovirus-like particles as vaccine vectors.

  1999cites this paper
• The poliovirus 135S particle is infectious

  1996cites this paper
• Activity‐related features of synapse morphology: A study of endbulbs of Held

  1996cites this paper
• Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope

  1995cites this paper
• Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature

  1994cites this paper
• Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans

  1993cites this paper
• Neutralization of Animal Viruses

  1993cites this paper
• Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions

  1992cites this paper
• Effects of hydrostatic pressure on a membrane-enveloped virus: high immunogenicity of the pressure-inactivated virus

  1992cites this paper
• Identification ofT-Helper Epitopes intheVP1Capsid Protein ofPoliovirus

  1992cites this paper
• Intrinsic immunogenicity of an internal VP1 T-B epitope pair of type 1 poliovirus.

  1992cites this paper
• Identification of T-helper epitopes in the VP1 capsid protein of poliovirus

  1992cites this paper
• Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus

  1992cites this paper
• Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions

  1992cites this paper
• Myristoylation is important at multiple stages in poliovirus assembly

  1991cites this paper
• Antigenic structure of picornaviruses.

  1990cites this paper
• Lysine and other diamines dramatically stabilize poliovirus against thermoinactivation.

  1990cites this paper
• Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1

  1990cites this paper
• Poliovirus vaccines. A continuing challenge.

  1990cites this paper
• Biosynthesis, maturation, and acid activation of the Semliki Forest virus fusion protein

  1990cites this paper
• Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.

  1989cites this paper
• Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.

  1989cites this paper
• A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system

  1989cites this paper
• Stabilization of poliovirus against heat inactivation.

  1989cites this paper
• Preparative separation of poliovirus structural polypeptides by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis, copper staining and electroelution, and induction of monospecific antisera

  1989cites this paper
• 3 – Vaccine Production by Recombinant DNA Technology

  1989cites this paper
• Viral vaccines and antivirals: current use and future prospects.

  1988cites this paper
• Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies

  1987cites this paper
• Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins.

  1987cites this paper
• Binding site of neutralizing monoclonal antibodies obtained after in vivo priming with purified VP1 of poliovirus type 1 is located between amino acid residues 93 and 104 of VP1.

  1987cites this paper
• Toward new viral vaccines for man.

  1987cites this paper
• Identification and characterization of a continuous neutralization epitope (C3) present on type 1 poliovirus.

  1987cites this paper
• Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site

  1986cites this paper
• Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.

  1986cites this paper
• Molecular approaches to vaccines.

  1986cites this paper
• The genetic basis for the attenuation of the sabin type 3 poliomyelitis vaccine, P3/Leon/12a1b.

  1986cites this paper
• Mapping Neutralization Domains of Viruses

  1986cites this paper
• Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.

  1985cites this paper
• Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points.

  1985cites this paper
• Polio vaccine: From empiricism and efficacyto scientific knowledge

  1985cites this paper
• Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.

  1985cites this paper
• Antigenic variation and resistance to neutralization in poliovirus type 1.

  1985cites this paper
• Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses

  1985cites this paper
• New approaches to vaccines.

  1985cites this paper
• Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.

  1984cites this paper
• Expression of poliovirus complementary DNA coding for viral antigenic determinants in Escherichia coli.

  1984cites this paper
• Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site

  1984cites this paper
• Virion orientation in cubic crystals of the human common cold virus HRV14.

  1984cites this paper
• The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.

  1984cites this paper
• Molecular genetics of poliovirus.

  1984cites this paper
• Peptide priming of a poliovirus neutralizing antibody response.

  1984cites this paper
• Structure, Proteolytic Processing, and Neutralization Antigenic Sites of Poliovirus

  1984cites this paper
• Picornaviruses and Togaviruses: Targets for Design of Antivirals

  1984cites this paper
• SESSION IV Molecular Genetics of Poliovirus

  1984cites this paper
• 4 – Synthesis of a Viral Membrane Protein in Bacillus subtilis

  1984cites this paper
• Expression of poliovirus capsid polypeptide VP1 in Escherichia coli.

  1983cites this paper
• Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1.

  1983cites this paper
• Virology: Neutralizing site of poliovirus

  1983cites this paper
• Molecular cloning and characterization of hepatitis A virus cDNA.

  1983cites this paper
• Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.

  1983cites this paper
• Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides

  1983cites this paper
• Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.

  1983cites this paper
• Induction of neutralizing antibodies by all three structural poliovirus polypeptides.

  1983cites this paper
• A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.

  1983cites this paper
• Type‐Specific and Cross‐Reactive Antigenicity of Capsid Proteins VP1 and VP2 of Echovirus Type 7

  1983cites this paper
• Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system.

  1983cites this paper
• Neutralizing site of poliovirus.

  1983cites this paper
• Cross antigenicity among enteroviruses as revealed by immunoblot technique.

  1983cites this paper
• A new genetics of poliovirus

  1982cites this paper